Thermo Fisher Scientific Overview
Valuation check: TMO's P/E ratio is 33.41, above the Healthcare sector average of 25.9.
Get informed when a big investor buys or sells
+ Follow33.41
The P/E ratio compares a company's stock price to its earnings per share. A lower P/E ratio may indicate that the stock is undervalued.
Thermo Fisher Scientific (TMO) currently reports a P/E ratio of 33.41. That is above the Healthcare sector average of 25.9. Use the charts on this page to explore Thermo Fisher Scientific's P/E ratio history and peer comparisons.
Thermo Fisher Scientific's P/E ratio of 33.41 is higher than the Healthcare sector average of 25.9. That is roughly 29.0% above the sector mean. A reading higher peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.
The P/E ratio is a valuation multiple that relates Thermo Fisher Scientific's market price to a fundamental measure such as earnings, sales, or book value. At 33.41, TMO can look expensive or cheap only in context — versus its own history, growth rate, and Healthcare peers. Higher multiples often price in stronger expected growth; lower ones can signal value or concern.
Start with the current P/E ratio of 33.41, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 25.9. From there, open related valuation or income-statement pages for Thermo Fisher Scientific, and consider following TMO for alerts when major investors trade the stock.
Thermo Fisher Scientific is classified in the Healthcare sector. On P/E ratio, it currently shows 33.41 versus a sector average near 25.9. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing TMO with unrelated industries.
